# Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms

> **NCT06268847** · NA · COMPLETED · sponsor: **Abyss Ingredients** · enrollment: 92 (actual)

## Conditions studied

- Atopic Dermatitis
- Eczema

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** ACT01
- **DIETARY_SUPPLEMENT:** ACT02

## Key facts

- **NCT ID:** NCT06268847
- **Lead sponsor:** Abyss Ingredients
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-09
- **Primary completion:** 2024-04-02
- **Final completion:** 2024-07-03
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2024-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06268847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06268847, "Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06268847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*